Literature DB >> 21204235

Two concurrent chromosomal aberrations involving interstitial deletion in 1q24.2q25.2 and inverted duplication and deletion in 10q26 in a patient with stroke associated with antithrombin deficiency and a patent foramen ovale.

Tetsuya Kibe1, Yuka Mori, Tohru Okanishi, Keiko Shimojima, Kenji Yokochi, Toshiyuki Yamamoto.   

Abstract

Advanced high-throughput molecular cytogenetic analysis has enabled the identification of small chromosomal rearrangements, and two or more concurrently occurring chromosomal rearrangements have been identified using this technique. A girl with severe psychomotor developmental delay associated with an uncertain abnormality (detected by conventional karyotyping) in chromosome 10q had a sudden stroke at the age of 35 months. Laboratory and radiographic examinations revealed antithrombin (AT) deficiency and a patent foramen ovale (PFO). Two concurrent chromosomal aberrations, inverted duplication and deletion in the 10q26 region and a microdeletion in the 1q24.2q25.2 region including the AT gene (SERPINC1), were identified by microarray-based comparative genomic hybridization analysis. Both chromosomal aberrations were found to be of paternal origin. This study described the concurrence of chromosomal rearrangements involving two chromosomes, and estimated the frequency of two or more chromosomal aberrations as 2-4%.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204235     DOI: 10.1002/ajmg.a.33786

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Cerebrovascular Events Secondary to Pulmonary Arteriovenous Malformation Based on Genetic Heterogeneity.

Authors:  Güner Çelik; Hüseyin Yurdakul; Erkan Yildirim
Journal:  Noro Psikiyatr Ars       Date:  2016-09-20       Impact factor: 1.339

2.  Inverted Duplication and Deletion of 10q25q26 in a Patient without Any Obvious Skeletal Anomalies.

Authors:  B Xiao; X Ji; Y Xing; W-T Jiang; J-M Zhang; J Tao
Journal:  Mol Syndromol       Date:  2012-09-27

3.  Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25.

Authors:  Deepika D'Cunha Burkardt; Jill A Rosenfeld; Maria L Helgeson; Brad Angle; Valerie Banks; Wendy E Smith; Karen W Gripp; Jessica Moline; Rocio T Moran; Dmitriy M Niyazov; Cathy A Stevens; Elaine Zackai; Robert Roger Lebel; Douglas G Ashley; Nancy Kramer; Ralph S Lachman; John M Graham
Journal:  Am J Med Genet A       Date:  2011-05-05       Impact factor: 2.802

Review 4.  Copy Number Variation and Risk of Stroke.

Authors:  Caspar Grond-Ginsbach; Philipp Erhart; Bowang Chen; Manja Kloss; Stefan T Engelter; John W Cole
Journal:  Stroke       Date:  2018-10       Impact factor: 7.914

5.  Distal trisomy 10q syndrome, report of a patient with duplicated q24.31 - qter, autism spectrum disorder and unusual features.

Authors:  Yasser Al-Sarraj; Hakam Abu Al-Khair; Rowaida Ziad Taha; Namat Khattab; Zakaria H El Sayed; Bushra Elhusein; Hatem El-Shanti
Journal:  Clin Case Rep       Date:  2014-07-25

6.  The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing.

Authors:  Jun Wang; Yan Wang; Liwen Wang; Wang Yang Chen; Min Sheng
Journal:  BMC Med Genomics       Date:  2020-05-19       Impact factor: 3.063

7.  The copy number variation and stroke (CaNVAS) risk and outcome study.

Authors:  John W Cole; Taiwo Adigun; Rufus Akinyemi; Onoja Matthew Akpa; Steven Bell; Bowang Chen; Jordi Jimenez Conde; Uxue Lazcano Dobao; Israel Fernandez; Myriam Fornage; Cristina Gallego-Fabrega; Christina Jern; Michael Krawczak; Arne Lindgren; Hugh S Markus; Olle Melander; Mayowa Owolabi; Kristina Schlicht; Martin Söderholm; Vinodh Srinivasasainagendra; Carolina Soriano Tárraga; Martin Stenman; Hemant Tiwari; Margaret Corasaniti; Natalie Fecteau; Beth Guizzardi; Haley Lopez; Kevin Nguyen; Brady Gaynor; Timothy O'Connor; O Colin Stine; Steven J Kittner; Patrick McArdle; Braxton D Mitchell; Huichun Xu; Caspar Grond-Ginsbach
Journal:  PLoS One       Date:  2021-04-19       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.